Despite biochemical, transgenic mouse and clinical studies offering potential explanations for the role of ApoE ε4 in AD progression, precise molecular mechanisms underlying ApoE ε4-mediated AD risk remains elusive. Here, APOE is linked to Alzheimer disease.